This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Behavioral remedies remain out of fashion at EU merger watchdog

By Andrew Boyce ( December 26, 2025, 11:07 GMT | Comment) -- The EU’s merger investigations in 2025 confirmed its strong preference for competition concerns to be addressed by “structural” remedies, rather than by “behavioral” ones. This year the European Commission approved nine deals with commitments, with all of those involving the divestiture of assets, rather than pledges over how the merged company would behave in the future. The stance could be tested in 2026, amid political pressure and with counterparts in the UK showing more openness to accept behavioral commitments.The European Commission’s merger investigations in 2025 confirmed its strong preference for competition concerns to be addressed by “structural” remedies, rather than by “behavioral” ones....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login